Loteprednol ophthalmic gel

loteprednol etabonate · Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Loteprednol ophthalmic gel, covering 2020-09-03 to 2020-09-03. Get the full timeline:

Most recent: Clinical Trial Update: Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [Phase 3]